Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers

Published:2012-10 Issue:10 Volume:23 Page:2663-2670
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Seront E.,Rottey S.,Sautois B.,Kerger J.,D'Hondt L.A.,Verschaeve V.,Canon J.-L.,Dopchie C.,Vandenbulcke J.M.,Whenham N.,Goeminne J.C.,Clausse M.,Verhoeven D.,Glorieux P.,Branders S.,Dupont P.,Schoonjans J.,Feron O.,Machiels J.-P.

Funder

Novartis

Televie

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/10/2663/13786293/mds057.pdf

Reference48 articles.

1. Cancer Facts & Figures;American Cancer Society,2011

2. Long term survival in metastatic transitional cell carcinoma and prognostic factors predicting outcome of therapy;Bajorin;J Clin Oncol,1999

3. Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study;Saxman;J Clin Oncol,1997

4. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer;von der Maase;J Clin Oncol,2005

5. Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract;Bellmunt;J Clin Oncol,2009

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual mTOR1/2 Inhibitor Sapanisertib (FTH-003/TAK-228) in Combination With Weekly Paclitaxel in Patients With Previously Treated Metastatic Urothelial Carcinoma: A Phase II Open-Label Study;Clinical Genitourinary Cancer;2024-10

2. Research Progress of Neoadjuvant Chemotherapy in Advanced Bladder Cancer;annals of urologic oncology;2024-08-20

3. Landscape of targeted therapies for advanced urothelial carcinoma;Exploration of Targeted Anti-tumor Therapy;2024-06-21

4. Genomic Profiling and Molecular Characterisation of Metastatic Urothelial Carcinoma;Medicina;2024-03-31

5. In Vivo and Clinical Studies of Natural Products Targeting the Hallmarks of Cancer;Handbook of Experimental Pharmacology;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3